4951 - 4960 of 7942 Results
Title
Year
- Development of a Disease Progression Model for Leucine‐Rich Repeat Kinase 2 in Parkinson's Disease to Inform Clinical Trial Designs2019OPENTitle: Development of a Disease Progression Model for Leucine‐Rich Repeat Kinase 2 in Parkinson's Disease to Inform Clinical Trial DesignsJournal Name: Clinical Pharmacology & TherapeuticsPublisher: WileyVol: 107Issue #: 3Start Page: 553End Page: 562Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/cpt.1634Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7939141Citation Count: 15
- Quadruple Decision Making for Parkinson’s Disease Patients: Combining Expert Opinion, Patient Preferences, Scientific Evidence, and Big Data Approaches to Reach Precision Medicine2019OPENTitle: Quadruple Decision Making for Parkinson’s Disease Patients: Combining Expert Opinion, Patient Preferences, Scientific Evidence, and Big Data Approaches to Reach Precision MedicineJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 10Issue #: 1Start Page: 223End Page: 231Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-191712Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd191712?id=journal-of-parkinsons-disease%2Fjpd191712Citation Count: 26
- How to evaluate effects of occupational therapy – lessons learned from an exploratory randomized controlled trial2019RESTRICTEDTitle: How to evaluate effects of occupational therapy – lessons learned from an exploratory randomized controlled trialJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 67Issue #:Start Page: 42End Page: 47Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.09.013Citation Count: 4
- Applications of amyloid, tau, and neuroinflammation PET imaging to Alzheimer's disease and mild cognitive impairment2019RESTRICTEDTitle: Applications of amyloid, tau, and neuroinflammation PET imaging to Alzheimer's disease and mild cognitive impairmentJournal Name: Human Brain MappingPublisher: WileyVol: 40Issue #: 18Start Page: 5424End Page: 5442Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1002/hbm.24782Best OA location URL: https://europepmc.org/articles/pmc6864887?pdf=renderCitation Count: 130
-
OPENTitle: mTOR hyperactivity mediates lysosomal dysfunction in Gaucher's disease iPSC-neuronal cellsJournal Name: Disease Models & MechanismsPublisher: The Company of BiologistsVol: 12Issue #: 10Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1242/dmm.038596Best OA location URL: https://dmm.biologists.org/content/dmm/12/10/dmm038596.full.pdfCitation Count: 52
- Microscopic Viscosity of Neuronal Plasma Membranes Measured Using Fluorescent Molecular Rotors: Effects of Oxidative Stress and Neuroprotection2019OPENTitle: Microscopic Viscosity of Neuronal Plasma Membranes Measured Using Fluorescent Molecular Rotors: Effects of Oxidative Stress and NeuroprotectionJournal Name: ACS Applied Materials & InterfacesPublisher: American Chemical Society (ACS)Vol: 11Issue #: 40Start Page: 36307End Page: 36315Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acsami.9b10426Best OA location URL: https://hdl.handle.net/10044/1/73521Citation Count: 41
- Proceedings of the Sixth Deep Brain Stimulation Think Tank Modulation of Brain Networks and Application of Advanced Neuroimaging, Neurophysiology, and Optogenetics2019OPENTitle: Proceedings of the Sixth Deep Brain Stimulation Think Tank Modulation of Brain Networks and Application of Advanced Neuroimaging, Neurophysiology, and OptogeneticsJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2019.00936Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2019.00936/pdfCitation Count: 29
- Genomewide association study of Parkinson's disease clinical biomarkers in 12 longitudinal patients' cohorts2019OPENTitle: Genomewide association study of Parkinson's disease clinical biomarkers in 12 longitudinal patients' cohortsJournal Name: Movement DisordersPublisher: WileyVol: 34Issue #: 12Start Page: 1839End Page: 1850Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.27845Best OA location URL: https://www.pure.ed.ac.uk/ws/files/112990604/Breen_GWAS_MovtDisorders.pdfCitation Count: 140
- Higher Urine bis(Monoacylglycerol)Phosphate Levels in LRRK2 G2019S Mutation Carriers: Implications for Therapeutic Development2019OPENTitle: Higher Urine bis(Monoacylglycerol)Phosphate Levels in LRRK2 G2019S Mutation Carriers: Implications for Therapeutic DevelopmentJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 1Start Page: 134End Page: 141Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.27818Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6981003Citation Count: 59
-
OPENTitle: Transportation innovation to aid Parkinson disease trial recruitmentJournal Name: Contemporary Clinical Trials CommunicationsPublisher: Elsevier BVVol: 16Issue #:Start Page: 100449End Page: 100449Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.conctc.2019.100449Best OA location URL: https://doi.org/10.1016/j.conctc.2019.100449Citation Count: 6